March 7th, 2025 |
Michael Goller |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
March 7th, 2025 |
Bros. Baker |
Director, 10 Percent Owner: |
Stock Award
|
64.00K |
$786.56K |
64.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Non-Qualified Stock Option (right to buy)uy) |
Stock Award
|
64000 |
$12.29 |
$786.56K |
|
March 7th, 2025 |
Bros. Baker |
Director, 10 Percent Owner: |
|
12.82M |
$- |
10.12M |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
|
0 |
$0.00 |
$- |
Common Stock |
|
0 |
$0.00 |
$- |
2020/2022 $0.0001 Prefunded Warrants |
|
4102636 |
$0.00 |
$- |
2024 $0.0001 Prefunded Warrants |
|
3518877 |
$0.00 |
$- |
$0.001 Prefunded Warrants |
|
5199583 |
$0.00 |
$- |
|
December 18th, 2024 |
Sushil Patel |
Director, Officer: Chief Executive Officer |
Sale
|
10.00K |
$124.20K |
202.01K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
10000 |
$12.42 |
$124.20K |
|
November 20th, 2024 |
Konstantinos Xynos |
Chief Medical Officer |
Sale
|
7.25K |
$78.11K |
109.89K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
7246 |
$10.78 |
$78.11K |
|
November 20th, 2024 |
Christopher Sarchi |
Chief Commercial Officer |
Sale
|
5.21K |
$56.13K |
87.05K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
5207 |
$10.78 |
$56.13K |
|
September 5th, 2024 |
Madhavan Balachandran |
Director |
Stock Award
|
64.00K |
$668.16K |
64.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Employee Stock Option (right to buy) |
Stock Award
|
64000 |
$10.44 |
$668.16K |
|
September 5th, 2024 |
Madhavan Balachandran |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
August 30th, 2024 |
Philip Astley-sparke |
Director, Officer: Executive Chairman |
Gift
|
50.00K |
$- |
1.44M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Gift
|
50000 |
$0.00 |
$- |
|
August 19th, 2024 |
Emily Hill |
Chief Financial Officer |
Sale
|
8.94K |
$90.99K |
101.06K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
8938 |
$10.18 |
$90.99K |
|
June 10th, 2024 |
Konstantinos Xynos |
Chief Medical Officer |
Sale
|
15.88K |
$119.11K |
117.13K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
15881 |
$7.50 |
$119.11K |
|
May 20th, 2024 |
Christopher Sarchi |
Chief Commercial Officer |
Sale
|
2.22K |
$14.35K |
92.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
2218 |
$6.47 |
$14.35K |
|
May 20th, 2024 |
Andrew Schwendenman |
Chief Accounting Officer |
Sale
|
2.30K |
$14.87K |
38.24K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
2298 |
$6.47 |
$14.87K |
|
May 20th, 2024 |
Colin Love |
Chief Operating Officer |
Sale
|
17.61K |
$113.97K |
777.35K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
17615 |
$6.47 |
$113.97K |
|
May 20th, 2024 |
Philip Astley-sparke |
Director, Officer: Executive Chairman |
Sale
|
37.93K |
$245.39K |
1.49M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
37928 |
$6.47 |
$245.39K |
|
May 20th, 2024 |
Robert Coffin |
Director |
Sale
|
11.46K |
$74.17K |
1.82M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
11464 |
$6.47 |
$74.17K |
|
May 20th, 2024 |
Sushil Patel |
Director, Officer: Chief Executive Officer |
Sale
|
20.19K |
$130.66K |
212.01K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
20194 |
$6.47 |
$130.66K |
|
May 20th, 2024 |
Konstantinos Xynos |
Chief Medical Officer |
Sale
|
6.37K |
$41.19K |
133.01K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
6367 |
$6.47 |
$41.19K |
|
April 3rd, 2024 |
Veleka Peeples-dyer |
Director |
Stock Award
|
32.00K |
$247.36K |
32.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
32000 |
$7.73 |
$247.36K |
|
April 3rd, 2024 |
Sushil Patel |
Director, Officer: Chief Executive Officer |
Stock Award
|
333.33K |
$1.93M |
250.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Employee Stock Option (right to buy) |
Stock Award
|
250000 |
$7.73 |
$1.93M |
Common Stock |
Stock Award
|
83335 |
$0.00 |
$- |
|
April 3rd, 2024 |
Paolo Pucci |
Director |
Stock Award
|
32.00K |
$247.36K |
32.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
32000 |
$7.73 |
$247.36K |
|
April 3rd, 2024 |
Konstantinos Xynos |
Chief Medical Officer |
Stock Award
|
106.67K |
$618.40K |
139.38K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
26665 |
$0.00 |
$- |
Employee Stock Option (right to buy) |
Stock Award
|
80000 |
$7.73 |
$618.40K |
|
April 3rd, 2024 |
Kapil Dhingra |
Director |
Stock Award
|
32.00K |
$247.36K |
32.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
32000 |
$7.73 |
$247.36K |
|
April 3rd, 2024 |
Emily Hill |
Chief Financial Officer |
Stock Award
|
106.67K |
$618.40K |
110.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
26665 |
$0.00 |
$- |
Employee Stock Option (right to buy) |
Stock Award
|
80000 |
$7.73 |
$618.40K |
|
April 3rd, 2024 |
Christopher Sarchi |
Chief Commercial Officer |
Stock Award
|
88.90K |
$515.40K |
94.47K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
22225 |
$0.00 |
$- |
Employee Stock Option (right to buy) |
Stock Award
|
66675 |
$7.73 |
$515.40K |
|
April 3rd, 2024 |
Joseph Slattery |
Director |
Stock Award
|
32.00K |
$247.36K |
32.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
32000 |
$7.73 |
$247.36K |
|
April 3rd, 2024 |
Dieter Weinand |
Director |
Stock Award
|
32.00K |
$247.36K |
32.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
32000 |
$7.73 |
$247.36K |
|
April 3rd, 2024 |
Christy Oliger |
Director |
Stock Award
|
32.00K |
$247.36K |
32.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
32000 |
$7.73 |
$247.36K |
|
April 3rd, 2024 |
Hyam Levitsky |
Director |
Stock Award
|
32.00K |
$247.36K |
32.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
32000 |
$7.73 |
$247.36K |
|
April 3rd, 2024 |
Andrew Schwendenman |
Chief Accounting Officer |
Stock Award
|
71.10K |
$412.20K |
53.33K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Employee Stock Option (right to buy) |
Stock Award
|
53325 |
$7.73 |
$412.20K |
Common Stock |
Stock Award
|
17775 |
$0.00 |
$- |
|
November 17th, 2023 |
Konstantinos Xynos |
Chief Medical Officer |
Sale
|
7.31K |
$79.86K |
112.71K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
7313 |
$10.92 |
$79.86K |
|
November 17th, 2023 |
Christopher Sarchi |
Chief Commercial Officer |
Sale
|
5.25K |
$57.38K |
72.25K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
5255 |
$10.92 |
$57.38K |
|
September 20th, 2023 |
Emily Hill |
Chief Financial Officer |
Stock Award
|
208.33K |
$2.25M |
125.00K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Employee Stock Option (right to buy) |
Stock Award
|
125000 |
$18.00 |
$2.25M |
Common Stock |
Stock Award
|
83330 |
$0.00 |
$- |
|
September 20th, 2023 |
Emily Hill |
Officer |
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
September 13th, 2023 |
Pamela Esposito |
Chief Business Officer |
Exercise Sale
|
16.97K |
$150.56K |
268.79K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
5358 |
$3.30 |
$17.68K |
Common Stock |
Exercise/Conversion
|
300 |
$3.30 |
$990 |
Common Stock |
Sale
|
300 |
$20.00 |
$6.00K |
Common Stock |
Sale
|
5358 |
$20.01 |
$107.21K |
Employee Stock Option (right to buy) |
Exercise/Conversion
|
5358 |
$3.30 |
$17.68K |
Employee Stock Option (right to buy) |
Exercise/Conversion
|
300 |
$3.30 |
$990 |
|
August 24th, 2023 |
Pamela Esposito |
Chief Business Officer |
Exercise Sale
|
55.80K |
$616.95K |
282.04K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
5000 |
$15.50 |
$77.50K |
Common Stock |
Exercise/Conversion
|
13600 |
$3.30 |
$44.88K |
Common Stock |
Sale
|
18600 |
$20.01 |
$372.19K |
Employee Stock Option (right to buy) |
Exercise/Conversion
|
13600 |
$3.30 |
$44.88K |
Employee Stock Option (right to buy) |
Exercise/Conversion
|
5000 |
$15.50 |
$77.50K |
|
August 15th, 2023 |
Pamela Esposito |
Chief Business Officer |
Exercise Sale
|
4.20K |
$37.24K |
264.84K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
1400 |
$3.30 |
$4.62K |
Common Stock |
Sale
|
1400 |
$20.00 |
$28.00K |
Employee Stock Option (right to buy) |
Exercise/Conversion
|
1400 |
$3.30 |
$4.62K |
|
July 26th, 2023 |
Christopher Sarchi |
Chief Commercial Officer |
|
116.25K |
$2.84M |
55.00K |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
|
0 |
$0.00 |
$- |
Common Stock |
|
0 |
$0.00 |
$- |
Employee Stock Option (right to buy) |
|
82500 |
$27.20 |
$2.24M |
Employee Stock Option (right to buy) |
|
33750 |
$17.66 |
$596.02K |
|
July 11th, 2023 |
Pamela Esposito |
Chief Business Officer |
Exercise Sale
|
60.00K |
$685.54K |
283.44K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Exercise/Conversion
|
5000 |
$15.50 |
$77.50K |
Common Stock |
Exercise/Conversion
|
15000 |
$3.30 |
$49.50K |
Common Stock |
Sale
|
17923 |
$21.63 |
$387.67K |
Common Stock |
Sale
|
2077 |
$21.12 |
$43.87K |
Employee Stock Option (right to buy) |
Exercise/Conversion
|
15000 |
$3.30 |
$49.50K |
Employee Stock Option (right to buy) |
Exercise/Conversion
|
5000 |
$15.50 |
$77.50K |
|
June 15th, 2023 |
Tanya Lewis |
Chief Dev. Op. Officer |
Sale
|
12.86K |
$309.39K |
136.11K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
12043 |
$24.10 |
$290.24K |
Common Stock |
Sale
|
817 |
$23.45 |
$19.16K |
|
June 15th, 2023 |
Sushil Patel |
Chief Strategy Officer |
Sale
|
5.70K |
$137.01K |
149.43K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
5145 |
$24.11 |
$124.05K |
Common Stock |
Sale
|
553 |
$23.44 |
$12.96K |
|
June 5th, 2023 |
Veleka Peeples-dyer |
Director |
Stock Award
|
50.40K |
$931.39K |
50.40K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Employee Stock Option (right to buy) |
Stock Award
|
50400 |
$18.48 |
$931.39K |
|
June 5th, 2023 |
Veleka Peeples-dyer |
|
|
- |
$- |
- |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
|
|
0 |
$0.00 |
$- |
|
May 18th, 2023 |
Andrew Schwendenman |
Chief Accounting Officer |
|
83.07K |
$1.84M |
22.76K |
Form 3
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
|
0 |
$0.00 |
$- |
Employee Stock Option (right to buy) |
|
50000 |
$22.88 |
$1.14M |
Employee Stock Option (right to buy) |
|
7189 |
$31.58 |
$227.03K |
Employee Stock Option (right to buy) |
|
16295 |
$18.26 |
$297.55K |
Employee Stock Option (right to buy) |
|
9585 |
$17.66 |
$169.27K |
|
May 18th, 2023 |
Sushil Patel |
Chief Strategy Officer |
Sale
|
15.57K |
$281.13K |
154.57K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
15575 |
$18.05 |
$281.13K |
|
May 18th, 2023 |
Robert Coffin |
Director, Officer: President & Chief R&D Officer |
Sale
|
7.86K |
$141.89K |
1.83M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
7861 |
$18.05 |
$141.89K |
|
May 18th, 2023 |
Tanya Lewis |
Chief Dev. Op. Officer |
Sale
|
12.21K |
$220.34K |
148.15K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
12207 |
$18.05 |
$220.34K |
|
May 18th, 2023 |
Colin Love |
Chief Operating Officer |
Sale
|
10.78K |
$194.49K |
794.96K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
10775 |
$18.05 |
$194.49K |
|
May 18th, 2023 |
Jean Franchi |
Chief Financial Officer |
Sale
|
11.35K |
$204.89K |
128.75K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
11351 |
$18.05 |
$204.89K |
|
May 18th, 2023 |
Konstantinos Xynos |
Chief Medical Officer |
Sale
|
771 |
$13.92K |
120.03K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
771 |
$18.05 |
$13.92K |
|
May 18th, 2023 |
Pamela Esposito |
Chief Business Officer |
Sale
|
5.97K |
$107.69K |
263.44K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
5966 |
$18.05 |
$107.69K |
|
May 18th, 2023 |
Philip Astley-sparke |
Director, Officer: Chief Executive Officer |
Sale
|
17.90K |
$323.13K |
1.53M |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Sale
|
17902 |
$18.05 |
$323.13K |
|
April 4th, 2023 |
Hugo Slootweg |
Director |
Stock Award
|
25.20K |
$445.03K |
25.20K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
25200 |
$17.66 |
$445.03K |
|
April 4th, 2023 |
Paolo Pucci |
Director |
Stock Award
|
25.20K |
$445.03K |
25.20K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
25200 |
$17.66 |
$445.03K |
|
April 4th, 2023 |
Kapil Dhingra |
Director |
Stock Award
|
25.20K |
$445.03K |
25.20K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
25200 |
$17.66 |
$445.03K |
|
April 4th, 2023 |
Joseph Slattery |
Director |
Stock Award
|
25.20K |
$445.03K |
25.20K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
25200 |
$17.66 |
$445.03K |
|
April 4th, 2023 |
Hyam Levitsky |
Director |
Stock Award
|
25.20K |
$445.03K |
25.20K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
25200 |
$17.66 |
$445.03K |
|
April 4th, 2023 |
Dieter Weinand |
Director |
Stock Award
|
37.80K |
$667.55K |
37.80K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
37800 |
$17.66 |
$667.55K |
|
April 4th, 2023 |
Christy Oliger |
Director |
Stock Award
|
25.20K |
$445.03K |
25.20K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Stock Option (right to buy) |
Stock Award
|
25200 |
$17.66 |
$445.03K |
|
April 4th, 2023 |
Pamela Esposito |
Chief Business Officer |
Stock Award
|
100.00K |
$1.06M |
269.40K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
40000 |
$0.00 |
$- |
Employee Stock Option (right to buy) |
Stock Award
|
60000 |
$17.66 |
$1.06M |
|
April 4th, 2023 |
Konstantinos Xynos |
Chief Medical Officer |
Stock Award
|
125.00K |
$1.32M |
120.80K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
50000 |
$0.00 |
$- |
Employee Stock Option (right to buy) |
Stock Award
|
75000 |
$17.66 |
$1.32M |
|
April 4th, 2023 |
Jean Franchi |
Chief Financial Officer |
Stock Award
|
112.50K |
$1.19M |
140.10K |
Form 4
|
Security |
Transaction |
Shares |
Price |
Value |
Common Stock |
Stock Award
|
45000 |
$0.00 |
$- |
Employee Stock Option (right to buy) |
Stock Award
|
67500 |
$17.66 |
$1.19M |
|